These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25501577)

  • 1. Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancer.
    Neuman BP; Eifler JB; Castanares M; Chowdhury WH; Chen Y; Mease RC; Ma R; Mukherjee A; Lupold SE; Pomper MG; Rodriguez R
    Clin Cancer Res; 2015 Feb; 21(4):771-80. PubMed ID: 25501577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.
    Kularatne SA; Thomas M; Myers CH; Gagare P; Kanduluru AK; Crian CJ; Cichocki BN
    Clin Cancer Res; 2019 Jan; 25(1):177-187. PubMed ID: 30201762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models.
    Zhang M; Kobayashi N; Zettlitz KA; Kono EA; Yamashiro JM; Tsai WK; Jiang ZK; Tran CP; Wang C; Guan J; Wu AM; Reiter RE
    Clin Cancer Res; 2019 Jan; 25(1):188-200. PubMed ID: 30301826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.
    Sonn GA; Behesnilian AS; Jiang ZK; Zettlitz KA; Lepin EJ; Bentolila LA; Knowles SM; Lawrence D; Wu AM; Reiter RE
    Clin Cancer Res; 2016 Mar; 22(6):1403-12. PubMed ID: 26490315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors.
    Lütje S; Heskamp S; Franssen GM; Frielink C; Kip A; Hekman M; Fracasso G; Colombatti M; Herrmann K; Boerman OC; Gotthardt M; Rijpkema M
    Theranostics; 2019; 9(10):2924-2938. PubMed ID: 31244933
    [No Abstract]   [Full Text] [Related]  

  • 6. Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study.
    Laydner H; Huang SS; Heston WD; Autorino R; Wang X; Harsch KM; Magi-Galluzzi C; Isac W; Khanna R; Hu B; Escobar P; Chalikonda S; Rao PK; Haber GP; Kaouk JH; Stein RJ
    Urology; 2013 Feb; 81(2):451-6. PubMed ID: 23374828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMA-targeted NIR probes for image-guided detection of prostate cancer.
    Cilibrizzi A; Wang JT; Memdouh S; Iacovone A; McElroy K; Jaffar N; Young JD; Hider RC; Blower P; Al-Jamal K; Abbate V
    Colloids Surf B Biointerfaces; 2022 Oct; 218():112734. PubMed ID: 35952398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate.
    Nakajima T; Mitsunaga M; Bander NH; Heston WD; Choyke PL; Kobayashi H
    Bioconjug Chem; 2011 Aug; 22(8):1700-5. PubMed ID: 21740058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronic acid formulation of near infrared fluorophores optimizes surgical imaging in a prostate tumor xenograft.
    Souchek JJ; Wojtynek NE; Payne WM; Holmes MB; Dutta S; Qi B; Datta K; LaGrange CA; Mohs AM
    Acta Biomater; 2018 Jul; 75():323-333. PubMed ID: 29890268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of targeted near-infrared imaging agents for prostate cancer.
    Wang X; Huang SS; Heston WD; Guo H; Wang BC; Basilion JP
    Mol Cancer Ther; 2014 Nov; 13(11):2595-606. PubMed ID: 25239933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection.
    Zhang L; Shi X; Li Y; Duan X; Zhang Z; Fu H; Yang X; Tian J; Hu Z; Cui M
    J Med Chem; 2021 Jun; 64(11):7735-7745. PubMed ID: 34047189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A PSMA-targeted theranostic agent for photodynamic therapy.
    Chen Y; Chatterjee S; Lisok A; Minn I; Pullambhatla M; Wharram B; Wang Y; Jin J; Bhujwalla ZM; Nimmagadda S; Mease RC; Pomper MG
    J Photochem Photobiol B; 2017 Feb; 167():111-116. PubMed ID: 28063300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low molecular weight PSMA-based fluorescent imaging agent for cancer.
    Chen Y; Dhara S; Banerjee SR; Byun Y; Pullambhatla M; Mease RC; Pomper MG
    Biochem Biophys Res Commun; 2009 Dec; 390(3):624-9. PubMed ID: 19818734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer.
    Secin FP; Serio A; Bianco FJ; Karanikolas NT; Kuroiwa K; Vickers A; Touijer K; Guillonneau B
    Eur Urol; 2007 Mar; 51(3):764-71. PubMed ID: 17098356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.
    Themelis G; Harlaar NJ; Kelder W; Bart J; Sarantopoulos A; van Dam GM; Ntziachristos V
    Ann Surg Oncol; 2011 Nov; 18(12):3506-13. PubMed ID: 21509632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.
    Chen Y; Pullambhatla M; Banerjee SR; Byun Y; Stathis M; Rojas C; Slusher BS; Mease RC; Pomper MG
    Bioconjug Chem; 2012 Dec; 23(12):2377-85. PubMed ID: 23157641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients.
    Schlomm T; Tennstedt P; Huxhold C; Steuber T; Salomon G; Michl U; Heinzer H; Hansen J; Budäus L; Steurer S; Wittmer C; Minner S; Haese A; Sauter G; Graefen M; Huland H
    Eur Urol; 2012 Aug; 62(2):333-40. PubMed ID: 22591631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apical surgical margins status in robot-assisted laparoscopic radical prostatectomy does not depend on disease characteristics.
    Tsivian M; Zilberman DE; Ferrandino MN; Madden JF; Mouraviev V; Albala DM
    J Endourol; 2012 Apr; 26(4):361-5. PubMed ID: 22192106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.